Why Afrezza May Not Work

[Northerner]

MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration in 2011 for further trials. While the company recently achieved positive results in its phase 3 trials and is hoping to file an NDA soon, there's a long story behind inhalable insulin that makes me uncomfortable with a stock completely focused on this product.

http://www.insidermonkey.com/blog/m...izer-inc-pfe-why-afrezza-may-not-work-242639/